Skip to Content
Merck
  • Deletion of the uracil permease gene confers cross-resistance to 5-fluorouracil and azoles in Candida lusitaniae and highlights antagonistic interaction between fluorinated nucleotides and fluconazole.

Deletion of the uracil permease gene confers cross-resistance to 5-fluorouracil and azoles in Candida lusitaniae and highlights antagonistic interaction between fluorinated nucleotides and fluconazole.

Antimicrobial agents and chemotherapy (2014-05-29)
Frédéric Gabriel, Ayman Sabra, Sofiane El-Kirat-Chatel, Sophie Pujol, Valérie Fitton-Ouhabi, Daniel Brèthes, Karine Dementhon, Isabelle Accoceberry, Thierry Noël
ABSTRACT

We characterized two additional membrane transporters (Fur4p and Dal4p) of the nucleobase cation symporter 1 (NCS1) family involved in the uptake transport of pyrimidines and related molecules in the opportunistic pathogenic yeast Candida lusitaniae. Simple and multiple null mutants were constructed by gene deletion and genetic crosses. The function of each transporter was characterized by supplementation experiments, and the kinetic parameters of the uptake transport of uracil were measured using radiolabeled substrate. Fur4p specifically transports uracil and 5-fluorouracil. Dal4p is very close to Fur4p and transports allantoin (glyoxyldiureide). Deletion of the FUR4 gene confers resistance to 5-fluorouracil as well as cross-resistance to triazoles and imidazole antifungals when they are used simultaneously with 5-fluorouracil. However, the nucleobase transporters are not involved in azole uptake. Only fluorinated pyrimidines, not pyrimidines themselves, are able to promote cross-resistance to azoles by both the salvage and the de novo pathway of pyrimidine synthesis. A reinterpretation of the data previously obtained led us to show that subinhibitory doses of 5-fluorocytosine, 5-fluorouracil, and 5-fluorouridine also were able to trigger resistance to fluconazole in susceptible wild-type strains of C. lusitaniae and of different Candida species. Our results suggest that intracellular fluorinated nucleotides play a key role in azole resistance, either by preventing azoles from targeting the lanosterol 14-alpha-demethylase or its catalytic site or by acting as a molecular switch for the triggering of efflux transport.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Ammonium-14N2,sulfate-16O4, 99.99 atom % 16O, 99.99 atom % 14N
Sigma-Aldrich
Ammonium-14N2 sulfate solution, 40 wt. % in H2O, 99.99 atom % 14N
Sigma-Aldrich
Ammonium sulfate-14N2 solution, 40 wt. % in H2O, 99.99 atom % 14N
Supelco
Digoxigenin, analytical standard
Sigma-Aldrich
5-Fluorouracil, ≥99% (HPLC), powder
Sigma-Aldrich
Fluorouracil, meets USP testing specifications
USP
Fluorouracil, United States Pharmacopeia (USP) Reference Standard
Supelco
5-Fluorouracil, analytical standard
Digoxigenin, European Pharmacopoeia (EP) Reference Standard
Supelco
Fluorouracil, Pharmaceutical Secondary Standard; Certified Reference Material
Flucytosine, European Pharmacopoeia (EP) Reference Standard
Fluorouracil, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Ammonium-14N2 sulfate, 99.99 atom % 14N
Sigma-Aldrich
Ammonium sulfate, 99.999% trace metals basis
Sigma-Aldrich
Ammonium sulfate, BioUltra, ≥99.0% (T)
Sigma-Aldrich
5-Fluorocytosine, nucleoside analog
Sigma-Aldrich
Ammonium sulfate, suitable for plant cell culture, ≥99.0%
Sigma-Aldrich
Uracil, BioReagent, suitable for cell culture
Sigma-Aldrich
Uracil, ≥99.0%
Sigma-Aldrich
Ammonium sulfate, BioXtra, ≥99.0%
Supelco
Ammonium sulfate, analytical standard, for Nitrogen Determination According to Kjeldahl Method, traceable to NIST SRM 194
Sigma-Aldrich
Ammonium sulfate, for molecular biology, ≥99.0%
Fluorouracil impurity C, European Pharmacopoeia (EP) Reference Standard
Supelco
Uracil, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Ammonium sulfate, anhydrous, Redi-Dri, ReagentPlus®, ≥99.0%
Sigma-Aldrich
Ammonium sulfate, ACS reagent, ≥99.0%
Sigma-Aldrich
Ammonium sulfate, ReagentPlus®, ≥99.0%
Flucytosine for system suitability, European Pharmacopoeia (EP) Reference Standard